These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1149002)

  • 1. Another hypothesis concerning the antitumor activity and cardiotoxicity of daunorubicin (NSC-82151) and adriamycin (NSC-123127).
    Wheeler DM
    Cancer Chemother Rep; 1975; 59(2 Pt 1):258-9. PubMed ID: 1149002
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: Daunomycin (NSC-82151) and adriamycin (NSC-123127): a hypothesis concerning antitumor activity and cardiotoxicity.
    Adamson RH
    Cancer Chemother Rep; 1974; 58(3):293-4. PubMed ID: 4841712
    [No Abstract]   [Full Text] [Related]  

  • 3. Some determinants of the therapeutic efficacy of actinomycin D (NSC-3053), adriamycin (NSC-123127), and daunorubicin (NSC-83142).
    Schwartz HS
    Cancer Chemother Rep; 1974; 58(1):55-62. PubMed ID: 4521481
    [No Abstract]   [Full Text] [Related]  

  • 4. The cardiotoxicity of adriamycin and daunomycin in children.
    Gilladoga AC; Manuel C; Tan CT; Wollner N; Sternberg SS; Murphy ML
    Cancer; 1976 Feb; 37(2 Suppl):1070-8. PubMed ID: 1253124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiotoxicity of anthracycline cytostatic agents--a proposal for routine monitoring and supportive therapy].
    Svojgrová M; Slechtová J; Hůla J
    Vnitr Lek; 1991 Feb; 37(2):151-9. PubMed ID: 2021075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of daunorubicin (NSC-83142) with adriamycin (NSC-123127) in the treatment of late-stage childhood solid tumors.
    Evans AE; Baehner RL; Chard RL; Leikin SL; Pang EM; Pierce M
    Cancer Chemother Rep; 1974; 58(5 Pt 1):671-6. PubMed ID: 4371948
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial: Adriamycin and the heart.
    Lancet; 1974 Jun; 1(7870):1325. PubMed ID: 4134302
    [No Abstract]   [Full Text] [Related]  

  • 8. Toxicologic screening of daunorubicin (NSC-82151), adriamycin (NSC-123127), and their derivatives in rats.
    Zbinden G; Brändle E
    Cancer Chemother Rep; 1975; 59(4):707-15. PubMed ID: 1175165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter: DNA complexes of daunorubicin (NSC-8215) and adriamycin (NSC-123127).
    Trouet A; de Duve C
    Cancer Chemother Rep; 1975; 59(2 Pt 1):260. PubMed ID: 1149004
    [No Abstract]   [Full Text] [Related]  

  • 10. Correlations between cytotoxicity, biochemical effects, drug levels, and therapeutic effectiveness of daunomycin and adriamycin on Sarcoma 180 ascites in mice.
    Silvestrini R; Lenaz L; Di Fronzo G; Sanfilippo O
    Cancer Res; 1973 Nov; 33(11):2954-8. PubMed ID: 4748447
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cardiotoxicity of cytostatics in long-term therapy].
    Bühner R
    Dtsch Med Wochenschr; 1978 Aug; 103(33):1311-2. PubMed ID: 98313
    [No Abstract]   [Full Text] [Related]  

  • 12. Adriamycin and daunorubicin: a comparison of antitumor activities and tissue uptake in mice following immunosuppression.
    Schwartz HS; Grindey GB
    Cancer Res; 1973 Aug; 33(8):1837-44. PubMed ID: 4720795
    [No Abstract]   [Full Text] [Related]  

  • 13. On the reported lack of effectiveness of daunomycin (NSC-82151) and adriamycin (NSC-123127) on solid tumors.
    Lenaz L; Di Marco A
    Cancer Chemother Rep; 1972 Aug; 56(4):431-2. PubMed ID: 5081585
    [No Abstract]   [Full Text] [Related]  

  • 14. Adriamycin-induced cardiotoxicity (cardiomyopathy and congestive heart failure) in rats.
    Mettler FP; Young DM; Ward JM
    Cancer Res; 1977 Aug; 37(8 Pt 1):2705-13. PubMed ID: 872096
    [No Abstract]   [Full Text] [Related]  

  • 15. Adriamycin (NSC-123127) and its analogs.
    Henry DW
    Cancer Chemother Rep 2; 1974 Dec; 4(4):5-9. PubMed ID: 4451911
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiac toxicity of adriamycin-DNA complex and rubidazone: evaluation by electrocardiogram and endomyocardial biopsy.
    Benjamin RS; Mason JW; Billingham ME
    Cancer Treat Rep; 1978 Jun; 62(6):935-9. PubMed ID: 667871
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiotoxicity in children treated with anthracyclines: the role of M-mode echocardiography.
    Galli MA; Conter V; Zanetto F; Jankovic M; Ferrari L; Baio G; Masera G
    Haematologica; 1987; 72(4):347-50. PubMed ID: 3117636
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter: Contact dermatitis associated with adriamycin (NSC-123127) and daunorubicin (NSC-82151).
    Reich SD; Bachur NR
    Cancer Chemother Rep; 1975; 59(4):677-8. PubMed ID: 1175160
    [No Abstract]   [Full Text] [Related]  

  • 19. DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA.
    Bodley A; Liu LF; Israel M; Seshadri R; Koseki Y; Giuliani FC; Kirschenbaum S; Silber R; Potmesil M
    Cancer Res; 1989 Nov; 49(21):5969-78. PubMed ID: 2551497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anthracycline analogs: the past, present, and future.
    Weiss RB; Sarosy G; Clagett-Carr K; Russo M; Leyland-Jones B
    Cancer Chemother Pharmacol; 1986; 18(3):185-97. PubMed ID: 2948729
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.